Versión de HTML Básico
56
Miguel A. Arrabal Polo
Dutasteride y diagnóstico de cáncer de próstata
negative biopsy: Results from the REDUCE study. J Urol. 2011; 185: 126-
31.
20. Muller RL, Gerber L, Moreira DM et al. Serum testosterone and
dihydrotestosterone and prostate cancer in the placebo arm of the reduc-
tion by dutasteride of prostate cancer events trial. Eur Urol. 2012; 62:
757-64.
21. Andriole GL, Marberger M, Roehrborn CG. Clinical usefulness
of serum prostate specific antigen for the detection of prostate cancer is
preserved in men receiving the dual 5α- reductase inhibitor dutasteride.
J Urol. 2006; 175: 1657-62.
22. Van Leeuwen PJ, Kölble K, Huland H et al. Prostate cancer detec-
tion and dutasteride: Utility and limitations of prostate-specific antigen in
men with previous negative biopsies. Eur Urol. 2011; 59: 183-90.
23. Roehrborn CG, Andriole GL, Wilson TH et al. Effect of dutaste-
ride on prostate biopsy rates and the diagnosis of prostate cancer in men
with lower urinary tract symptoms and enlarged prostates in the combi-
nation of Avodart and tamsulosin trial. EurUrol.2011; 59: 244-9.
24. Barqawi AB, O´Donnell CI, Slomos VJ et al. The effect of short-
term dutasteride intake in early-stage prostate cancer: Analysis of 148
patients who underwent three-dimensional prostate mapping biopsy.
Urology.2010; 76: 1067-71.
25. Bostwick DG, Qian J, Drewnowska K et al. Prostate needle bi-
opsy quality in reduction by dutasteride of prostate cancer events study:
Worldwide comparison of improvement with investigator training and
centralized laboratory processing. Urology.2010; 75: 1406-11.
26. Kaplan SA, Lee RK, Chung DE et al. Prostate biopsy in response
to a change in nadir prostate specific antigen of 0.4 ng/ml after treat-
ment with 5α-reductase inhibitors markedly enhances the detection rate
of prostate cancer. J Urol. 2012; 188: 757-61.
27. Zaytoun OM, Jones JS. Prostate cancer detection after a nega-
tive prostate biopsy: Lessons learnt in the Cleveland Clinic experience. Int
J Urol. 2011; 18: 557-68.